Aim of the
study supported by the Campania Oncoterapie project is to improve available
treatments for oncological patients using strategies tailored to the specific
characteristics of each single patient.
During the last decade, an evolutionary step has been achieved in the medical science-omic sciences improved tremendously our ability to obtain large dataset of data with sustainable costs (high throughput screening). Today, clinical practice is based on limited amount of biomarkers used as target, nonetheless, even these superficial screening improved the clinicians ability of to choose the most efficient therapies.
Progress in oncology allowed improved pharmacological efficiency together with mass screening that allows identifying neoplastic lesions at early time point when success chances are much higher.
We now aim to move forward and better discriminate between tumors. Using an “high quality picture” approach we will identify the specific characteristics of patients and tumors allowing the clinician to proceed with the optimal therapy available. Furthermore, we aim to use the recently developed 3D cell culture techniques to perform pharmacological studies to identify new and more efficient molecules.